Dofetilide recalls
Dofetilide products have been recalled 4 times, most recently on 16 Aug 2023. The recalling company is usually Accord Healthcare. The most common reason is manufacturing (cgmp) deviations.
Total recalls4since 2023
Last 12 months0reported
Class I00% of total
Ongoing0latest 16 Aug 2023
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 3 75%Class III 1 25%
Why dofetilide is recalled
Companies
By year
All dofetilide recalls, newest first
4 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | Dofetilide Capsules 500 mcg 5mg) recalledDofetilide | Sun Pharmaceutical Industries | Potency & Assay | Nationwide |
| Drug | CLASS II | Dofetilide Capsules, 125 mcg 125 mg) recalled by Accord HealthcareDofetilide | Accord Healthcare | Manufacturing (CGMP) Deviations | PR |
| Drug | CLASS II | Dofetilide Capsules 500 mcg 5 mg) recalled by Accord HealthcareDofetilide | Accord Healthcare | Manufacturing (CGMP) Deviations | PR |
| Drug | CLASS II | Dofetilide Capsules 250 mcg 25 mg) recalled by Accord HealthcareDofetilide | Accord Healthcare | Manufacturing (CGMP) Deviations | PR |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.